Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?

Published:2022-12-08 Issue:1 Volume:57 Page:177-178
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Trebicka Jonel¹²^ORCID,Zarbock Alexander³

Affiliation:

1. Department of Internal Medicine B University of Münster Münster Germany

2. European Foundation for the Study of Chronic Liver Failure Barcelona Spain

3. Department of Anesthesiology, Intensive Care and Pain Medicine University of Münster Münster Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17244

Reference7 articles.

1. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure

2. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

3. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

4. S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”

5. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study);Digestive Diseases and Sciences;2024-04-18

2. New Insights into Antioxidant Peptides: An Overview of Efficient Screening, Evaluation Models, Molecular Mechanisms, and Applications;Antioxidants;2024-02-05

3. Editorial: terlipressin in patients withACLFgrade 3—too late? Authorsʼ reply;Alimentary Pharmacology & Therapeutics;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3